Ledger.Open graph →
SEC Form D · filed February 23, 2018

Crinetics Pharmaceuticals, Inc

Offering
$65.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Matthew K. Fust · San Diego, CADirectorMason S. Freeman, M.D · San Diego, CADirectorWendell S. Wierenga, Ph.D · San Diego, CADirectorRichard S. Struthers, Ph.D · San Diego, CAExec · DirectorSteve S. Kaldor, Ph.D · San Diego, CADirectorMarc S. Wilson · San Diego, CAExecWeston K. Nichols, Ph.D · San Diego, CADirectorJack B. Nielsen · 3584 CM Utrecht, P7DirectorMason S. Freeman, M.D · San Diego, CADirectorMatthew K. Fust · Redwood City, CADirectorWendell S. Wierenga, Ph.D · San Diego, CADirectorRichard S. Struthers, Ph.D · San Diego, CAExec · DirectorSteve S. Kaldor, Ph.D · San Diego, CADirectorMarc S. Wilson · San Diego, CAExecWeston K. Nichols, Ph.D · San Diego, CADirectorJack B. Nielsen · 3584 CM Utrecht, P7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗